Literature DB >> 31955544

[Correlation between histone methylation level and pathological development of osteoarthritis].

Xiaotian Du1,2, Hongwei Ouyang1,2,3.   

Abstract

Osteoarthritis is the most common degenerative cartilage disease. A large number of studies have shown the close association between epigenetics and osteoarthritis. Histone methylation is a type of epigenetic modification, and the link between histone methylation and osteoarthritis has also been revealed. In this article, we summarize the correlation between methylation levels of different histones and osteoarthritis in an attempt to explore the changes and regulation mechanisms of histone methylation in osteoarthritis. It has been shown that there are possible relations between the methylation levels of different amino acids on histone H3 and the pathological development of osteoarthritis; specifically, the rise of methylation level at the lysine 4 would aggravate the pathological development of osteoarthritis, while the the pattern of lysine 9 and 27 would be the opposite. These results indicate the possible existence of a complex network of histone methylation modifications. And the specific regulation of histone methylation levels in different positions may delay or prevent the occurrence and development of osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31955544      PMCID: PMC8800784          DOI: 10.3785/j.issn.1008-9292.2019.12.14

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  46 in total

1.  Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1.

Authors:  Joanna Wysocka; Michael P Myers; Carol D Laherty; Robert N Eisenman; Winship Herr
Journal:  Genes Dev       Date:  2003-04-01       Impact factor: 11.361

2.  KDM6A promotes chondrogenic differentiation of periodontal ligament stem cells by demethylation of SOX9.

Authors:  Pingting Wang; Yanjing Li; Tingting Meng; Junjiang Zhang; Yuanyuan Wei; Zhaosong Meng; Yunfeng Lin; Dayong Liu; Lei Sui
Journal:  Cell Prolif       Date:  2017-11-23       Impact factor: 6.831

Review 3.  Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritis.

Authors:  Sergio Portal-Núñez; Pedro Esbrit; María José Alcaraz; Raquel Largo
Journal:  Biochem Pharmacol       Date:  2015-12-19       Impact factor: 5.858

Review 4.  Osteoarthritis - an untreatable disease?

Authors:  Heike A Wieland; Martin Michaelis; Bernhard J Kirschbaum; Karl A Rudolphi
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

Review 5.  Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis.

Authors:  Rui Zhang; Jie Ma; Jing Han; Weijie Zhang; Jianbing Ma
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 6.  Aging-related inflammation in osteoarthritis.

Authors:  M A Greene; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

7.  Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis.

Authors:  Martha C Castaño Betancourt; Frederic Cailotto; Hanneke J Kerkhof; Frederique M F Cornelis; Sally A Doherty; Deborah J Hart; Albert Hofman; Frank P Luyten; Rose A Maciewicz; Massimo Mangino; Sarah Metrustry; Kenneth Muir; Marjolein J Peters; Fernando Rivadeneira; Maggie Wheeler; Weiya Zhang; Nigel Arden; Tim D Spector; Andre G Uitterlinden; Michael Doherty; Rik J U Lories; Ana M Valdes; Joyce B J van Meurs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

8.  The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt/β-catenin pathway.

Authors:  Linwei Chen; Yaosen Wu; Yan Wu; Ye Wang; Liaojun Sun; Fangcai Li
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

9.  Anti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes.

Authors:  Juliette Aury-Landas; Céline Bazille; Lyess Allas; Sara Bouhout; Christophe Chesneau; Sylvain Leclercq; Karim Boumédiene; Catherine Baugé
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

10.  Local delivery of tetramethylpyrazine eliminates the senescent phenotype of bone marrow mesenchymal stromal cells and creates an anti-inflammatory and angiogenic environment in aging mice.

Authors:  Bo Gao; Xisheng Lin; Huan Jing; Jing Fan; Chenchen Ji; Qiang Jie; Chao Zheng; Di Wang; Xiaolong Xu; Yaqian Hu; Weiguang Lu; Zhuojing Luo; Liu Yang
Journal:  Aging Cell       Date:  2018-02-28       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.